Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel

Page 3 of 14

Page 3 of 14 – SEC Filing
CUSIP No.
761299106
1.
NAME OF REPORTING PERSONS:  Scopia Management, Inc.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
3,598,222
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
3,598,222
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,598,222
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.86%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 3 of 14